XML 49 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Note 8 - Segment and Geographic Data - Summary by Reporting and Operating Segments (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Product sales, net $ 2,248,845 $ 2,597,598  
Operating Income (Loss) (1,465,068) (1,342,676)  
Depreciation and Amortization 11,684 17,220  
Income (loss) before taxes and equity in earnings of affiliates (1,440,529) (1,319,331)  
Total assets 11,350,786   $ 11,371,512
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]      
Operating Income (Loss) (1,599,150) (1,162,683)  
Depreciation and Amortization 11,684 15,084  
Income (loss) before taxes and equity in earnings of affiliates (1,573,108) (1,136,732)  
Total assets 5,656,220   6,159,532
Dental Segment [Member]      
Product sales, net 2,241,425 2,591,398  
Dental Segment [Member] | Operating Segments [Member]      
Product sales, net 2,241,425 2,591,398  
Operating Income (Loss) 625,510 641,940  
Depreciation and Amortization 0 1,168  
Income (loss) before taxes and equity in earnings of affiliates 624,512 641,169  
Total assets 5,180,123   4,866,786
Medical Segment [Member]      
Product sales, net 7,420 6,200  
Medical Segment [Member] | Operating Segments [Member]      
Product sales, net 7,420 6,200  
Operating Income (Loss) (491,428) (821,933)  
Depreciation and Amortization 0 968  
Income (loss) before taxes and equity in earnings of affiliates (491,933) $ (823,768)  
Total assets $ 514,443   $ 345,194